Search the Newsreel

MapLight Therapeutics (MPLT) CMO reports 47,158-share stock sale

MapLight Therapeutics, Inc.'s Chief Medical Officer, Erin Pennock Foff, sold a total of 47,158 shares of Voting Common Stock between July 15 and July 17, 2026. These transactions included sales made under a Rule 10b5-1 trading plan adopted in December 2025 and "sell to …

MapLight Therapeutics CSO Lillie James Woodruff sells $673K in shares By Investing.com

Lillie James Woodruff, CSO of MapLight Therapeutics (NASDAQ:MPLT), sold shares worth $673,636 to cover tax withholding obligations related to restricted stock units. Despite this "sell to cover" transaction, which is mandatory under company equity plans, MapLight Therapeutics has recently received positive analyst coverage and …

Form 144 MapLight Therapeutics For: 17 July By Investing.com

This article from Investing.com announces the filing of Form 144 for MapLight Therapeutics on July 17. Form 144 indicates an insider's intent to sell restricted or control securities. The brief notice provides the company name and date of the filing.

MapLight Therapeutics CMO sells $1.73m in stock

Erin Pennock Foff, CMO of MapLight Therapeutics (NASDAQ: MPLT), sold approximately $1.73 million worth of company stock between July 15 and July 17, 2026. A significant portion of these sales was to cover tax withholding obligations related to restricted stock units, with some shares …

MapLight Therapeutics Insiders Sold Shares Worth Over $6.7M

Insiders at MapLight Therapeutics, including the CEO, CSO, and General Counsel, sold voting common stock between July 15-17, 2026. The total value of shares sold exceeded $6.7 million, with CEO Christopher A. Kroeger accounting for over $5.4 million of the sales. Following these transactions, …

Appili Therapeutics Inc Class A Actuals & Estimates (TSX:APLI)

CAPLIPOINT Forecast — Price Target — Prediction for 2027

Caplin Point Laboratories Limited (NSE:CAPLIPOINT) Looks Like A Good Stock, And It's Going Ex-Dividend Soon

Caplin Point Q4 FY26 Earnings Call Transcript Available

CAPLIPOINT: FY26 revenue up 13.2% and PAT up 20.1%, with robust cash reserves and no debt

Caplin Point Laboratories Submits Q4FY26 SEBI Compliance Certificate

MapLight Therapeutics, Inc. Rings the Nasdaq Stock Market Closing Bell

Caplin Point Laboratories Limited's (NSE:CAPLIPOINT) Share Price Not Quite Adding Up

Caplin Point Labs Q3FY26 Results: Revenue Up 10.1% to ₹542.8 Cr, Earnings Call Audio Now Available

Caplin Point Laboratories Schedules Q3FY26 Earnings Conference Call for February 05, 2026

Caplin Point Laboratories Limited's (NSE:CAPLIPOINT) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?

Caplin Point Laboratories Ltd. Share Price Live Today

Caplin Point Laboratories' (NSE:CAPLIPOINT) five-year earnings growth trails the strong shareholder returns

Do Caplin Point Laboratories' (NSE:CAPLIPOINT) Earnings Warrant Your Attention?

Maplight Therapeutics (MPLT) Stock Price, News & Analysis

MapLight Therapeutics (MPLT) Stock News

Caplin Point Laboratories Limited's (NSE:CAPLIPOINT) top holders are insiders and they are likely disappointed by the recent 3.4% drop

We Discuss Whether Caplin Point Laboratories Limited's (NSE:CAPLIPOINT) CEO Is Due For A Pay Rise

Caplin Point Laboratories Q4 Results

Appili Therapeutics Inc (APLI-T) Stock Price and News